These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21471168)

  • 41. Pituitary-independent effect of octreotide on IGF1 generation.
    Pokrajac A; Frystyk J; Flyvbjerg A; Trainer PJ
    Eur J Endocrinol; 2009 Apr; 160(4):543-8. PubMed ID: 19141605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study.
    Giordano C; Ciresi A; Amato MC; Pivonello R; Auriemma RS; Grasso LF; Galluzzo A; Colao A
    Pituitary; 2012 Dec; 15(4):539-51. PubMed ID: 22116639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus Somatostatin Analog Treatment.
    Dal J; Høyer KL; Pedersen SB; Magnusson NE; Bjerring P; Frystyk J; Møller N; Jessen N; Jørgensen JO
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3716-3723. PubMed ID: 27466699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preliminary data on biochemical remission of acromegaly after somatostatin analogs withdrawal.
    Ronchi CL; Rizzo E; Lania AG; Pivonello R; Grottoli S; Colao A; Ghigo E; Spada A; Arosio M; Beck-Peccoz P
    Eur J Endocrinol; 2008 Jan; 158(1):19-25. PubMed ID: 18166813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Characteristics of Acromegalic Patients With Paradoxical GH Response to Oral Glucose Load.
    Mukai K; Otsuki M; Tamada D; Kitamura T; Hayashi R; Saiki A; Goto Y; Arita H; Oshino S; Morii E; Saitoh Y; Shimomura I
    J Clin Endocrinol Metab; 2019 May; 104(5):1637-1644. PubMed ID: 30476255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Divergence between growth hormone and insulin-like growth factor-i concentrations in the follow-up of acromegaly.
    Alexopoulou O; Bex M; Abs R; T'Sjoen G; Velkeniers B; Maiter D
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1324-30. PubMed ID: 18230660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of Long-Acting Somatostatin Analogues on Lipid Metabolism in Patients with Newly Diagnosed Acromegaly: A Retrospective Study of 120 Cases.
    Shao XQ; Chen ZY; Wang M; Yang YP; Yu YF; Liu WJ; Wang Y; Zeng FF; Gong W; Ye HY; Wang YF; Zhao Y; Zhang L; Zhang ZY; He M; Li YM
    Horm Metab Res; 2022 Jan; 54(1):25-32. PubMed ID: 34986497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum prostate-specific antigen concentration is increased in acromegalic women.
    Manetti L; Lupi I; Genovesi M; Morselli L; Grasso L; Nencetti C; Gasperi M; Bogazzi F; Bartalena L; Martino E
    J Endocrinol Invest; 2004; 27(7):643-7. PubMed ID: 15505987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy).
    Colao A; Vandeva S; Pivonello R; Grasso LF; Nachev E; Auriemma RS; Kalinov K; Zacharieva S
    Eur J Endocrinol; 2014 Aug; 171(2):263-73. PubMed ID: 24878680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Body Composition and Ectopic Lipid Changes With Biochemical Control of Acromegaly.
    Bredella MA; Schorr M; Dichtel LE; Gerweck AV; Young BJ; Woodmansee WW; Swearingen B; Miller KK
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4218-4225. PubMed ID: 28945897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapy of acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to normalise IGF1 levels.
    Droste M; Domberg J; Buchfelder M; Mann K; Schwanke A; Stalla G; Strasburger CJ
    Eur J Endocrinol; 2014 Jul; 171(1):59-68. PubMed ID: 24913198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased mammographic breast density in acromegaly: quantitative and qualitative assessment.
    Tagliafico A; Calabrese M; Tagliafico G; Resmini E; Martinoli C; Rebora A; Colao A; Pivonello R; Ferone D
    Eur J Endocrinol; 2011 Mar; 164(3):335-40. PubMed ID: 21156646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postoperative Changes in Metabolic Parameters of Patients with Surgically Controlled Acromegaly: Assessment of New Stringent Cure Criteria.
    Yonenaga M; Fujio S; Habu M; Arimura H; Hiwatari T; Tanaka S; Kinoshita Y; Hosoyama H; Hirano H; Arita K
    Neurol Med Chir (Tokyo); 2018 Apr; 58(4):147-155. PubMed ID: 29479042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease.
    Davi' MV; Dalle Carbonare L; Giustina A; Ferrari M; Frigo A; Lo Cascio V; Francia G
    Eur J Endocrinol; 2008 Nov; 159(5):533-40. PubMed ID: 18765561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural and functional changes of carotid wall properties in patients with acromegaly are not restored after 1 year of GH/IGF1 normalization.
    Găloiu S; Jurcuţ R; Vlădaia A; Florian A; Purice M; Popescu BA; Ginghină C; Coculescu M
    Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):238-43. PubMed ID: 22426806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acromegaly and pregnancy: a prospective study.
    Dias M; Boguszewski C; Gadelha M; Kasuki L; Musolino N; Vieira JG; Abucham J
    Eur J Endocrinol; 2014 Feb; 170(2):301-10. PubMed ID: 24247731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry.
    Fieffe S; Morange I; Petrossians P; Chanson P; Rohmer V; Cortet C; Borson-Chazot F; Brue T; Delemer B;
    Eur J Endocrinol; 2011 Jun; 164(6):877-84. PubMed ID: 21464140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly.
    Postma MR; Netea-Maier RT; van den Berg G; Homan J; Sluiter WJ; Wagenmakers MA; van den Bergh AC; Wolffenbuttel BH; Hermus AR; van Beek AP
    Eur J Endocrinol; 2012 Apr; 166(4):585-92. PubMed ID: 22250074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long term effect of external pituitary irradiation on IGF1 levels in patients with acromegaly free of adjunctive treatment.
    Mullan K; Sanabria C; Abram WP; McConnell EM; Courtney HC; Hunter SJ; McCance DR; Leslie H; Sheridan B; Atkinson AB
    Eur J Endocrinol; 2009 Oct; 161(4):547-51. PubMed ID: 19661126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glucose tolerance and somatostatin analog treatment in acromegaly: a 12-month study.
    Colao A; Auriemma RS; Savastano S; Galdiero M; Grasso LF; Lombardi G; Pivonello R
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2907-14. PubMed ID: 19491229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.